Analysis of the Cochrane Review: Cortisteroid Implants for Chronic Non-Infectious Uveitis.

被引:0
|
作者
Leal, Ines [1 ,2 ]
Sousa, David Cordeiro [1 ,2 ]
Costa, Joao [3 ,4 ]
Vaz-Carneiro, Antonio [3 ,4 ]
机构
[1] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Serv Oftalmol, Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Ctr Estudos Ciencias Visao, Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Ctr Estudos Med Baseada Evidencia, Lisbon, Portugal
[4] Univ Lisbon, Fac Med, Ctr Colaborador Portugues Rede Cochrane Iberoamer, Lisbon, Portugal
来源
ACTA MEDICA PORTUGUESA | 2018年 / 31卷 / 05期
关键词
Adrenal Cortex Hormones/administration & dosage; Drug Implants; Randomized Controlled Trials as Topic; Uveitis/drug therapy;
D O I
10.20344/amp.10660
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-infectious uveitis is a heterogeneous collection of inflammatory eye diseases and is one of the most important causes of blindness among active adults in developed countries. Inflammation control is crucial in the prevention of ocular structural and functional damage. Regarding acute inflammatory control, corticosteroids are the mainstay of treatment. Several types of intra-ocular corticosteroids have been used with the aim of enhanced efficacy compared to their topical or peri-ocular administration, while minimizing its adverse effects associated with the systemic administration. The purpose of this Cochrane review was to synthetize the available evidence regarding the efficacy and safety of corticosteroid implants in comparison with standard treatment. Due to the heterogeneity in the design of the studies and outcome measures assessed, authors could not conclude that implants are superior to traditional systemic therapy in Non-infectious uveitis. The safety analysis suggested increased risks of post-implant surgery for cataract and high intraocular pressure compared with standard-of-care therapy.
引用
收藏
页码:243 / 246
页数:4
相关论文
共 50 条
  • [31] Immunosuppressive chemotherapy for non-infectious uveitis
    Calonge, M
    Bringas, R
    Herreras, JM
    [J]. SOE '97 - XI CONGRESS OF THE EUROPEAN SOCIETY OF OPHTHALMOLOGY, VOLS 1 AND 2, 1997, : 643 - 648
  • [32] Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review
    Joltikov, Katherine A.
    Lobo-Chan, Ann-Marie
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [33] A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis
    Srilakshmi M. Sharma
    Dun Jack Fu
    Kanmin Xue
    [J]. Ophthalmology and Therapy, 2018, 7 : 1 - 17
  • [34] A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis
    Sharma, Srilakshmi M.
    Fu, Dun Jack
    Xue, Kanmin
    [J]. OPHTHALMOLOGY AND THERAPY, 2018, 7 (01) : 1 - 17
  • [35] Adalimumab in the treatment of non-infectious uveitis
    Burek-Michalska, Alicja
    Turno-Krecicka, Anna
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (10): : 1231 - 1236
  • [36] Rituximab for non-infectious Uveitis and Scleritis
    Ng, Caleb C.
    Sy, Aileen
    Cunningham, Emmett T., Jr.
    [J]. JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2021, 11 (01)
  • [37] Rituximab for non-infectious Uveitis and Scleritis
    Caleb C. Ng
    Aileen Sy
    Emmett T. Cunningham
    [J]. Journal of Ophthalmic Inflammation and Infection, 11
  • [38] Chronic tuberculous uveitis, a resurgent and often missed cause of infectious uveitis.
    Cimino, L
    Tran, VT
    Auer, C
    Herbort, CP
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S460 - S460
  • [39] Tocilizumab in adult non-infectious uveitis
    Lo, Tiffany
    Rogers, Sophie
    Ross, Laura
    Bosco, Julian
    Lim, Lyndell
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [40] Immunomodulatory Therapy for non-infectious Uveitis
    Heinz, C.
    [J]. OPHTHALMOLOGE, 2019, 116 (10): : 917 - 917